Home
About Us
Core Team
Development History
Corporate Culture
S&T
Research Areas
Technology Platforms
Research and Development
Marketed Products
R&D Products
R&D Pipeline
Academic Progress
Blog
Company News
Media Reports
Join Us
Post-Doctoral Center
Contact Us
Biotech Pharma Participates in the "Boda Cup Citizen Fluorescent Night Run" Event
View details
→
[Case Share] Issue 186: A Case Report on Nilotinib Treatment for Pancreatic Cancer
[Breaking News] We warmly congratulate Nivolumab on being included as a Grade I expert recommendation in the 2022 CSCO Guidelines for the Diagnosis and Treatment of Pancreatic Cancer!
Professor Qin Shukai: Nilotinib Shows Breakthrough in Pancreatic Cancer Treatment—A Brief Discussion on Advances in Pancreatic Cancer Therapy
[Case Share] Issue 185: Long-Term Nivolumab Plus Chemotherapy for Advanced Nasopharyngeal Cancer
[Case Share] Issue 184: Combining Nimotuzumab for the Treatment of Advanced Nasopharyngeal Cancer